222 related articles for article (PubMed ID: 14660675)
1. bcl-2 induction of urokinase plasminogen activator receptor expression in human cancer cells through Sp1 activation: involvement of ERK1/ERK2 activity.
Trisciuoglio D; Iervolino A; Candiloro A; Fibbi G; Fanciulli M; Zangemeister-Wittke U; Zupi G; Del Bufalo D
J Biol Chem; 2004 Feb; 279(8):6737-45. PubMed ID: 14660675
[TBL] [Abstract][Full Text] [Related]
2. Suppression of urokinase receptor expression by bikunin is associated with inhibition of upstream targets of extracellular signal-regulated kinase-dependent cascade.
Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
Eur J Biochem; 2002 Aug; 269(16):3945-57. PubMed ID: 12180971
[TBL] [Abstract][Full Text] [Related]
3. MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription.
Benasciutti E; Pagès G; Kenzior O; Folk W; Blasi F; Crippa MP
Blood; 2004 Jul; 104(1):256-62. PubMed ID: 15031204
[TBL] [Abstract][Full Text] [Related]
4. Nerve growth factor uses Ras/ERK and phosphatidylinositol 3-kinase cascades to up-regulate the N-methyl-D-aspartate receptor 1 promoter.
Liu A; Prenger MS; Norton DD; Mei L; Kusiak JW; Bai G
J Biol Chem; 2001 Nov; 276(48):45372-9. PubMed ID: 11571288
[TBL] [Abstract][Full Text] [Related]
5. Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2.
Tran H; Maurer F; Nagamine Y
Mol Cell Biol; 2003 Oct; 23(20):7177-88. PubMed ID: 14517288
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway.
Qiao M; Shapiro P; Kumar R; Passaniti A
J Biol Chem; 2004 Oct; 279(41):42709-18. PubMed ID: 15304489
[TBL] [Abstract][Full Text] [Related]
7. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
Bessard A; Frémin C; Ezan F; Coutant A; Baffet G
J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199
[TBL] [Abstract][Full Text] [Related]
8. Macrophages survive hyperoxia via prolonged ERK activation due to phosphatase down-regulation.
Nyunoya T; Monick MM; Powers LS; Yarovinsky TO; Hunninghake GW
J Biol Chem; 2005 Jul; 280(28):26295-302. PubMed ID: 15901735
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin (UbC) expression in muscle cells is increased by glucocorticoids through a mechanism involving Sp1 and MEK1.
Marinovic AC; Zheng B; Mitch WE; Price SR
J Biol Chem; 2002 May; 277(19):16673-81. PubMed ID: 11872750
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia/reoxygenation induction of monocyte chemoattractant protein-1 in melanoma cells: involvement of nuclear factor-kappaB, stimulatory protein-1 transcription factors and mitogen-activated protein kinase pathways.
Kunz M; Bloss G; Gillitzer R; Gross G; Goebeler M; Rapp UR; Ludwig S
Biochem J; 2002 Aug; 366(Pt 1):299-306. PubMed ID: 12020348
[TBL] [Abstract][Full Text] [Related]
11. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling.
Aguirre Ghiso JA; Kovalski K; Ossowski L
J Cell Biol; 1999 Oct; 147(1):89-104. PubMed ID: 10508858
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines.
Bhattacharya A; Lakka SS; Mohanam S; Boyd D; Rao JS
Clin Cancer Res; 2001 Feb; 7(2):267-76. PubMed ID: 11234878
[TBL] [Abstract][Full Text] [Related]
13. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D
Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 positively regulates Sox9-dependent chondrocyte gene expression by suppressing the MEK-ERK1/2 signaling pathway.
Yagi R; McBurney D; Horton WE
J Biol Chem; 2005 Aug; 280(34):30517-25. PubMed ID: 15975921
[TBL] [Abstract][Full Text] [Related]
15. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
16. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH
Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.
Bryan L; Paugh BS; Kapitonov D; Wilczynska KM; Alvarez SM; Singh SK; Milstien S; Spiegel S; Kordula T
Mol Cancer Res; 2008 Sep; 6(9):1469-77. PubMed ID: 18819934
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
Wu W; Pew T; Zou M; Pang D; Conzen SD
J Biol Chem; 2005 Feb; 280(6):4117-24. PubMed ID: 15590693
[TBL] [Abstract][Full Text] [Related]
19. Endothelial exposure to hypoxia induces Egr-1 expression involving PKCalpha-mediated Ras/Raf-1/ERK1/2 pathway.
Lo LW; Cheng JJ; Chiu JJ; Wung BS; Liu YC; Wang DL
J Cell Physiol; 2001 Sep; 188(3):304-12. PubMed ID: 11473356
[TBL] [Abstract][Full Text] [Related]
20. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells.
Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
Int J Cancer; 2002 Dec; 102(4):379-89. PubMed ID: 12402308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]